2,655 Shares in Cardinal Health, Inc. $CAH Purchased by Fairvoy Private Wealth LLC

Fairvoy Private Wealth LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAHFree Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,655 shares of the company’s stock, valued at approximately $561,000.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after buying an additional 617,775 shares in the last quarter. State Street Corp raised its holdings in Cardinal Health by 1.8% in the 4th quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after acquiring an additional 221,497 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after acquiring an additional 43,924 shares during the period. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares during the period. Finally, Norges Bank acquired a new stake in shares of Cardinal Health during the 4th quarter worth $790,344,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.7%

Shares of Cardinal Health stock opened at $234.70 on Friday. The firm’s 50 day moving average is $205.54 and its 200 day moving average is $210.11. The firm has a market capitalization of $54.97 billion, a PE ratio of 35.89, a price-to-earnings-growth ratio of 1.27 and a beta of 0.52. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $237.79.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on CAH shares. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. Citigroup reduced their price objective on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. cut their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $246.93.

View Our Latest Research Report on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Further Reading

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.